These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
282 related items for PubMed ID: 20360159
1. Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test. Andreasen JT, Nielsen EØ, Christensen JK, Olsen GM, Peters D, Mirza NR, Redrobe JP. J Psychopharmacol; 2011 Oct; 25(10):1347-56. PubMed ID: 20360159 [Abstract] [Full Text] [Related]
2. Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests. Andreasen JT, Redrobe JP. Behav Brain Res; 2009 Jan 30; 197(1):150-6. PubMed ID: 18786574 [Abstract] [Full Text] [Related]
3. Combined α7 nicotinic acetylcholine receptor agonism and partial serotonin transporter inhibition produce antidepressant-like effects in the mouse forced swim and tail suspension tests: a comparison of SSR180711 and PNU-282987. Andreasen JT, Redrobe JP, Nielsen EØ. Pharmacol Biochem Behav; 2012 Jan 30; 100(3):624-9. PubMed ID: 22108649 [Abstract] [Full Text] [Related]
4. Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests. Andreasen JT, Olsen GM, Wiborg O, Redrobe JP. J Psychopharmacol; 2009 Sep 30; 23(7):797-804. PubMed ID: 18583432 [Abstract] [Full Text] [Related]
7. The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats. Hajós M, Hurst RS, Hoffmann WE, Krause M, Wall TM, Higdon NR, Groppi VE. J Pharmacol Exp Ther; 2005 Mar 30; 312(3):1213-22. PubMed ID: 15523001 [Abstract] [Full Text] [Related]
8. Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests. Takahashi E, Katayama M, Niimi K, Itakura C. Eur J Pharmacol; 2008 Jul 28; 589(1-3):149-56. PubMed ID: 18571641 [Abstract] [Full Text] [Related]
9. Activation of α7 nicotinic acetylcholine receptors ameliorates indomethacin-induced small intestinal ulceration in mice. Kawahara R, Yasuda M, Hashimura H, Amagase K, Kato S, Takeuchi K. Eur J Pharmacol; 2011 Jan 10; 650(1):411-7. PubMed ID: 20969854 [Abstract] [Full Text] [Related]
10. The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent. Pałucha-Poniewiera A, Brański P, Lenda T, Pilc A. J Pharmacol Exp Ther; 2010 Sep 01; 334(3):1066-74. PubMed ID: 20562216 [Abstract] [Full Text] [Related]
11. Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380. Caldarone BJ, Wang D, Paterson NE, Manzano M, Fedolak A, Cavino K, Kwan M, Hanania T, Chellappan SK, Kozikowski AP, Olivier B, Picciotto MR, Ghavami A. Psychopharmacology (Berl); 2011 Sep 01; 217(2):199-210. PubMed ID: 21487659 [Abstract] [Full Text] [Related]
12. New quinoline derivatives as nicotinic receptor modulators. Manetti D, Bellucci C, Dei S, Teodori E, Varani K, Spirova E, Kudryavtsev D, Shelukhina I, Tsetlin V, Romanelli MN. Eur J Med Chem; 2016 Mar 03; 110():246-58. PubMed ID: 26840365 [Abstract] [Full Text] [Related]
13. Inhibitory effects of beta-amyloid on the nicotinic receptors which stimulate glutamate release in rat hippocampus: the glial contribution. Salamone A, Mura E, Zappettini S, Grilli M, Olivero G, Preda S, Govoni S, Marchi M. Eur J Pharmacol; 2014 Jan 15; 723():314-21. PubMed ID: 24275353 [Abstract] [Full Text] [Related]
14. 3-Furan-2-yl-N-p-tolyl-acrylamide, a highly selective positive allosteric modulator of α7 nicotinic receptors, produces anxiolytic-like activity in mice. Targowska-Duda KM, Budzynska B, Michalak A, Jozwiak K, Biala G, Arias HR. J Psychopharmacol; 2019 May 15; 33(5):558-567. PubMed ID: 30644335 [Abstract] [Full Text] [Related]
15. Role of mouse cerebellar nicotinic acetylcholine receptor (nAChR) α(4)β(2)- and α(7) subtypes in the behavioral cross-tolerance between nicotine and ethanol-induced ataxia. Taslim N, Soderstrom K, Dar MS. Behav Brain Res; 2011 Mar 01; 217(2):282-92. PubMed ID: 20974182 [Abstract] [Full Text] [Related]
16. 5-HT(1A)-receptor over-expressing mice: genotype and sex dependent responses to antidepressants in the forced swim-test. Günther L, Rothe J, Rex A, Voigt JP, Millan MJ, Fink H, Bert B. Neuropharmacology; 2011 Sep 01; 61(3):433-41. PubMed ID: 21419787 [Abstract] [Full Text] [Related]
19. The subtype-selective nicotinic acetylcholine receptor positive allosteric potentiator 2087101 differentially facilitates neurotransmission in the brain. de Filippi G, Mogg AJ, Phillips KG, Zwart R, Sher E, Chen Y. Eur J Pharmacol; 2010 Sep 25; 643(2-3):218-24. PubMed ID: 20624387 [Abstract] [Full Text] [Related]
20. Analysis of gene expression profiles in rat hippocampus following treatment with nicotine and an alpha7 nAChR selective agonist. Waring JF, Abel S, Li J, Bitner RS, Nikkel AL, Blomme EA, Anderson DJ, Gopalakrishnan M. Neurosci Res; 2008 Mar 25; 60(3):266-74. PubMed ID: 18164502 [Abstract] [Full Text] [Related] Page: [Next] [New Search]